Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

BACKGROUND: Screening and diagnosis of prostate cancer (PCa) is hampered by an inability to predict who has the potential to develop fatal disease and who has indolent cancer. Studies have identified multiple genetic risk loci for PCa incidence, but it is unknown whether they could be used as biomar...

Full description

Bibliographic Details
Main Authors:	Shui, I, Lindström, S, Kibel, A, Berndt, S, Campa, D, Gerke, T, Penney, K, Albanes, D, Berg, C, Bueno-de-Mesquita, H, Chanock, S, Crawford, E, Diver, W, Gapstur, S, Gaziano, J, Giles, G, Henderson, B, Hoover, R, Johansson, M, Le Marchand, L, Ma, J, Navarro, C, Overvad, K, Schumacher, F, Severi, G
Format:	Journal article
Language:	English
Published:	2014

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Similar Items